The impact of statin therapy on in‐hospital prognosis and endothelial function of patients at high‐to‐very high cardiovascular risk admitted for COVID‐19

Statins may protect against adverse outcomes from Coronavirus disease 2019 (COVID‐19) through their pleiotropic effects. Endothelial dysfunction seems to be implicated in the pathophysiology of COVID‐19, and can be attenuated by statins. This study assessed the role of preadmission statin therapy an...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of medical virology 2023-03, Vol.95 (3), p.e28678-n/a
Hauptverfasser:	Bianconi, Vanessa, Mannarino, Massimo R., Cosentini, Elena, Figorilli, Filippo, Colangelo, Cecilia, Cellini, Giulia, Braca, Marco, Lombardini, Rita, Paltriccia, Rita, Sahebkar, Amirhossein, Pirro, Matteo
Format:	Artikel
Sprache:	eng
Schlagworte:	cardiovascular Cardiovascular diseases Cardiovascular Diseases - drug therapy Coronaviruses COVID-19 Endothelium Endothelium, Vascular FMD Health risks Heart Disease Risk Factors Hospital Mortality Hospitals Humans Hydroxymethylglutaryl-CoA Reductase Inhibitors - adverse effects Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use Prognosis Retrospective Studies Risk Factors Risk management SARS‐CoV‐2 statin Statins Subgroups Therapy Viral diseases Virology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!